Celebrating the excellence of our newly-named ‘Young Tall Poppies’, the success of an emergency mental health intervention program to reduce harmful behaviours in a hospital setting, and the launch of new graduate course units to boost clinical research in translational medicine. Plus, the COVID-19 response continues apace. Here’s just some of what has happened this week across the Alfred Research Alliance.
BAKER HEART AND DIABETES INSTITUTE
Dr Rachel Climie Named as Young Tall Poppy
Baker Institute postdoctoral researcher Dr Rachel Climie has been named one of 12 outstanding researchers from Victoria named in the 2020 Young Tall Poppy Science Awards. Run by the Australian Institute of Policy and Science (AIPS), the Awards honour up-and-coming scientists who combine world-class research with a passionate commitment to communicating science. Rachel is a Heart Foundation Postdoctoral Fellow who works in the Baker Institute’s Sports Cardiology laboratory with a research focus on vascular ageing. Read more…
Burnet Helps Answer Crucial Questions About COVID-19
Since Australia’s first case of COVID-19 was confirmed just over 200 days ago, we have accumulated a phenomenal amount of knowledge about this disease but fundamental questions remain unanswered. The Australian Financial Review this week published an article by Health Editor Jill Margo, posing those crucial questions to three leading scientists including Burnet’s Director and CEO, Professor Brendan Crabb AC. You can read a summary of the article or click here to view the entire AFR article online. (Image – AFR)
Positive Impact of Psy-BOC Emergency Mental Health Intervention in IPU
The Alfred psychiatry inpatient team has recently published three research articles in Australian Psychiatry, looking at how implementing the ‘psychiatric behaviours of concern’ (Psy-BOC) at The Alfred in 2017 has significantly decreased harmful behaviours and aggression towards staff by getting the right people, at the right time, to intervene. Read more…
MONASH CENTRAL CLINICAL SCHOOL
New Clinical & Translational Medicine Education Units Launched
From the Frontline: Clinical Impacts of COVID-19 – Watch it Now
More than 1,500 viewers enjoyed From the Frontline: Clinical Impacts of COVID-19 webinar last Wednesday, gaining insights on the societal effects of the disease and current endeavours to develop viable vaccines and anti-viral therapies, as well as recent adaptations to the provision of healthcare for those impacted by chronic disease. They also heard how a single-voice for COVID-19 evidence has been established. If you missed it, you can watch it here or read the wrap.
Researcher Dr Crispin Szydzik from then Australian Centre for Blood Diseases (ACBD) has been awarded the RMIT David Beanland Prize for Best PhD Thesis in Engineering in 2019, for his engineering innovations to streamline production of customised ‘lab-on-a-chips’ – microchips for speeding up biomedical analysis. The technology Crispin developed can shrink whole pathology lab assays and mimic organs on a chip the size of a microscope slide, to sense environmental contaminants, biomolecules and cancer cell studies, and help find new anti-clotting drugs for heart attacks and strokes. Read more…
MONASH PUBLIC HEALTH & PREVENTIVE MEDICINE
Yuming Guo Recognised with Young Tall Poppy Science Award
Prof Yuming Guo from Monash SPHPM has been recognised with a 2020 Tall Poppy Science Award, and the Tony McMichael Award – named after Monash SPHPM’s first PhD in Epidemiology – from the International Society for Environmental Epidemiology. Professor Guo has achieved over 150 peer-reviewed publications since joining Monash University in 2017 and leads a global collaborative research program which will help decision-makers plan for the effects of climate change on global health. Read more…